# Study of Sirolimus in IgG4-related Disease

> **NCT05746689** · NA · NOT_YET_RECRUITING · sponsor: **Peking University International Hospital** · enrollment: 20 (estimated)

## Conditions studied

- IgG4-related Disease

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT05746689
- **Lead sponsor:** Peking University International Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05746689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05746689, "Study of Sirolimus in IgG4-related Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05746689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*